靶向突变-话题@MedSci

#靶向突变#

6篇内容 | 594人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2194148, encodeId=e2032194148a0, content=<a href='/topic/show?id=594853956a' target=_blank style='color:#2F92EE;'>#ctDNA#</a> <a href='/topic/show?id=44bb9993531' target=_blank style='color:#2F92EE;'>#靶向突变#</a>, objectTitle=JAMA子刊：临床研究表明，基于NCCN指南靶向突变的组织与ctDNA并行检测具有临床益处, objectType=article, longId=816553, objectId=3a79816553cf, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, objectUrl=/article/show_article.do?id=3a79816553cf, replyNumber=0, likeNumber=22, createdTime=2024-03-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3a79816553cf, moduleTitle=JAMA子刊：临床研究表明，基于NCCN指南靶向突变的组织与ctDNA并行检测具有临床益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a79816553cf)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1993886, encodeId=2fac199388671, content=<a href='/topic/show?id=44bb9993531' target=_blank style='color:#2F92EE;'>#靶向突变#</a>, objectTitle=Prostate Cancer P D：ReACp53靶向突变p53蛋白在CRPC中的治疗潜力, objectType=article, longId=179438, objectId=0b321e943813, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b321e943813, replyNumber=0, likeNumber=37, createdTime=2020-03-27, rootId=0, userName=fangcong, userId=b79433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b321e943813, moduleTitle=Prostate Cancer P D：ReACp53靶向突变p53蛋白在CRPC中的治疗潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b321e943813)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993883, encodeId=95511993883d6, content=<a href='/topic/show?id=44bb9993531' target=_blank style='color:#2F92EE;'>#靶向突变#</a>, objectTitle=Oncotarget：“多子丸”克罗米芬靶向突变IDH1抗癌, objectType=article, longId=98167, objectId=6d5e9816e82, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d5e9816e82, replyNumber=0, likeNumber=43, createdTime=2017-12-19, rootId=0, userName=fangcong, userId=b79433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d5e9816e82, moduleTitle=Oncotarget：“多子丸”克罗米芬靶向突变IDH1抗癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d5e9816e82)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993885, encodeId=4131199388591, content=<a href='/topic/show?id=44bb9993531' target=_blank style='color:#2F92EE;'>#靶向突变#</a>, objectTitle=FDA：尘埃落定！“靶向突变”的基因疗法获批上市！, objectType=article, longId=124065, objectId=3c781240654e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c781240654e, replyNumber=0, likeNumber=0, createdTime=2018-10-22, rootId=0, userName=fangcong, userId=b79433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c781240654e, moduleTitle=FDA：尘埃落定！“靶向突变”的基因疗法获批上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c781240654e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993884, encodeId=8e3d199388461, content=<a href='/topic/show?id=44bb9993531' target=_blank style='color:#2F92EE;'>#靶向突变#</a>, objectTitle=好消息！16:0！“靶向突变”的基因疗法获FDA专家团一致认可, objectType=article, longId=116235, objectId=f69311623518, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f69311623518, replyNumber=0, likeNumber=30, createdTime=2018-04-29, rootId=0, userName=fangcong, userId=b79433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f69311623518, moduleTitle=好消息！16:0！“靶向突变”的基因疗法获FDA专家团一致认可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f69311623518)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993882, encodeId=3bdf1993882ff, content=<a href='/topic/show?id=44bb9993531' target=_blank style='color:#2F92EE;'>#靶向突变#</a>, objectTitle=Nat Biotechnol：在体内利用电穿孔运送CRISPR/Cpf1实现靶向突变, objectType=article, longId=70253, objectId=9dd5e025381, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dd5e025381, replyNumber=0, likeNumber=36, createdTime=2016-09-17, rootId=0, userName=fangcong, userId=b79433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dd5e025381, moduleTitle=Nat Biotechnol：在体内利用电穿孔运送CRISPR/Cpf1实现靶向突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dd5e025381)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993881, encodeId=aab71993881ce, content=<a href='/topic/show?id=44bb9993531' target=_blank style='color:#2F92EE;'>#靶向突变#</a>, objectTitle=Nat Genet：发现难治性肿瘤的可靶向突变, objectType=article, longId=29429, objectId=ee6129429de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee6129429de, replyNumber=0, likeNumber=41, createdTime=2014-05-06, rootId=0, userName=fangcong, userId=b79433, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee6129429de, moduleTitle=Nat Genet：发现难治性肿瘤的可靶向突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee6129429de)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

靶向突变

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#ctDNA# #靶向突变#

JAMA子刊：临床研究表明，基于NCCN指南靶向突变的组织与ctDNA并行检测具有临床益处

2024-03-19发表于上海

fangcong (审核中...)

前往app查看评论内容

#靶向突变#

Prostate Cancer P D：ReACp53靶向突变p53蛋白在CRPC中的治疗潜力

2020-03-27

fangcong (审核中...)

前往app查看评论内容

#靶向突变#

Oncotarget：“多子丸”克罗米芬靶向突变IDH1抗癌

2017-12-19

fangcong (审核中...)

前往app查看评论内容

#靶向突变#

FDA：尘埃落定！“靶向突变”的基因疗法获批上市！

2018-10-22

fangcong (审核中...)

前往app查看评论内容

#靶向突变#

好消息！16:0！“靶向突变”的基因疗法获FDA专家团一致认可

2018-04-29

fangcong (审核中...)

前往app查看评论内容

#靶向突变#

Nat Biotechnol：在体内利用电穿孔运送CRISPR/Cpf1实现靶向突变

2016-09-17

fangcong (审核中...)

前往app查看评论内容

#靶向突变#

Nat Genet：发现难治性肿瘤的可靶向突变

2014-05-06

科室
- - 订阅+
  - 更多科室
工具
服务